Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.
about
Involvement of a small GTP binding protein in HIV-1 release.Cell fusion activity of hepatitis C virus envelope proteinsReplacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidatesReplacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates.The carboxy-terminal sequence of the pestivirus glycoprotein E(rns) represents an unusual type of membrane anchor.Polypurine (A)-rich sequences promote cross-kingdom conservation of internal ribosome entry.Palmitoylation and Polymerization of Hepatitis C Virus NS4B ProteinMutation of Cysteine 171 of Pestivirus Erns RNase Prevents Homodimer Formation and Leads to Attenuation of Classical Swine Fever VirusA New Type of Signal Peptidase Cleavage Site Identified in an RNA Virus PolyproteinNewcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.The stability of human respiratory syncytial virus is enhanced by incorporation of the baculovirus GP64 protein.Mutational analysis of the candidate internal fusion peptide of the avian leukosis and sarcoma virus subgroup A envelope glycoprotein.Actin cytoskeletal reorganizations and coreceptor-mediated activation of rac during human immunodeficiency virus-induced cell fusionIdentification of temperature-sensitive mutations in the phosphoprotein of respiratory syncytial virus that are likely involved in its interaction with the nucleoprotein.Elimination of phosphorylation sites of Semliki Forest virus replicase protein nsP3.Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates.Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein.Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity.Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine.Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaReverse genetics system for porcine enteric calicivirus, a prototype sapovirus in the Caliciviridae.Identification of internal sequences in the 3' leader region of human respiratory syncytial virus that enhance transcription and confer replication processivity.Three amino acid substitutions in the L protein of the human parainfluenza virus type 3 cp45 live attenuated vaccine candidate contribute to its temperature-sensitive and attenuation phenotypesRecovery of a fully viable chimeric human parainfluenza virus (PIV) type 3 in which the hemagglutinin-neuraminidase and fusion glycoproteins have been replaced by those of PIV type 1.Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles.Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection.A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates.Rescue of mumps virus from cDNA.Recovery of pathogenic measles virus from cloned cDNAHuman parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy.Effect of inserting paramyxovirus simian virus 5 gene junctions at the HN/L gene junction: analysis of accumulation of mRNAs transcribed from rescued viable viruses.Involvement of the cytoplasmic domain of the hemagglutinin-neuraminidase protein in assembly of the paramyxovirus simian virus 5Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms.Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cellsRecombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.Requirement of cysteines and length of the human respiratory syncytial virus M2-1 protein for protein function and virus viabilityDNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirusFeline calicivirus can tolerate gross changes of its minor capsid protein expression levels induced by changing translation reinitiation frequency or use of a separate VP2-coding mRNA.Replication and packaging of Norwalk virus RNA in cultured mammalian cells.Evidence that the polymerase of respiratory syncytial virus initiates RNA replication in a nontemplated fashion.
P2860
Q24815862-BBEB7C42-2C6C-44F9-841F-4899C23D5545Q27469594-42504D45-2E22-4F5C-8ED2-E1BE02254883Q27469676-5F5F98A0-F66E-412F-95E6-634320FCDD3BQ27469749-4334FCF4-C21B-42A5-9DD0-FEF86B771F07Q27471499-C68ED07E-6FCA-4102-B425-2BA8DB54A12BQ27471765-5384992E-AF1B-4762-B201-A5E3F22080CDQ27473233-13316392-3065-41E2-B0A1-AFE8C5C309C5Q27488398-227BD3DF-E1AF-4057-A72E-F43694B507B9Q27491169-5135ABA0-4528-48C8-9B21-BD6BF22CF524Q30357521-61631D43-5FEC-474E-B5C8-59CC92337F9EQ30440686-1C70ED1D-777E-45E0-BCB8-FA22F85B47E1Q30453530-A188993E-E7B8-4F05-8C84-47215A064513Q30596706-C83F610B-AFEC-42C7-8496-49F1217BC389Q30818098-F4C5B5F8-6BC5-44A5-A117-C8C5244F733EQ31649623-C19E1F1B-A9DB-46D2-AB64-71E2B0D02884Q33604189-BABE71CD-1B3C-482A-8E84-88F1F10B0DC5Q33639543-52939E29-28F2-4903-BD0C-1A74DB4178BAQ33640019-91C42AF4-0FAB-4F7B-AF30-4D4B3294E144Q33641383-E4EF1A8B-1594-42DA-8DA3-100DD522983DQ33707803-83486B5A-41F5-4C46-AB87-2BA4D3ED2F0EQ33718109-8021CE0F-36CA-4872-BA9B-D3D7784D131EQ33782234-EBC68E58-3461-430B-BA7F-80067F26ED53Q33782252-69D8D480-5D1B-44E3-BED2-8294F7A4DC32Q33783083-610AC510-BFBE-47B9-9810-8F65FAF7D788Q33785124-23834860-90D5-4444-870E-258AA4FC2D49Q33787265-4D3F83AA-7839-4382-8EB0-61EFDD37222EQ33801293-D9810EF9-79B3-46C5-A517-D06A913D9F2DQ33804946-79A4D1AD-CE95-4429-9F3E-CB71B9262229Q33808180-F1DD83D1-4677-45BB-BA35-FC39FB1EA469Q33808578-7FD329FB-1730-4455-82C4-98322713639FQ33816333-F052F1AE-9016-4DCC-8EE7-69C95078738DQ33820965-762CE8B8-CEB3-4D63-87AB-17AC243192B9Q33836560-621834A7-D292-42AF-A7C4-9CB75AF3CB0DQ33838481-04796C55-6E8D-4CA0-A1F0-C424DB866D8FQ33840469-A24FC8D9-B647-4EBF-8AE2-1D7662B591F3Q33849620-ABD3E0AE-9267-4D1C-99FB-4B70F8B6A921Q33853499-26E0C927-6CAD-45F7-A44B-B5FD4ADD5951Q33875277-B7E9C3C0-9C90-4800-8B7A-D3C375E029AAQ33900425-2A0A4D93-98C6-4144-8D6F-FE03AD3E4858Q33933216-A7521D56-298E-452E-8A27-0E2840A3AF45
P2860
Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Replication-deficient vaccinia ...... expression in mammalian cells.
@en
type
label
Replication-deficient vaccinia ...... expression in mammalian cells.
@en
prefLabel
Replication-deficient vaccinia ...... expression in mammalian cells.
@en
P2093
P356
P1433
P1476
Replication-deficient vaccinia ...... expression in mammalian cells.
@en
P2093
P304
P356
10.1006/VIRO.1995.1332
P407
P577
1995-06-01T00:00:00Z